InvestorsObserver
×
News Home

Is Fortress Biotech Inc (FBIO) a Bad Choice in Biotechnology Friday?

Friday, December 01, 2023 10:27 AM | InvestorsObserver Analysts

Mentioned in this article

Is Fortress Biotech Inc (FBIO) a Bad Choice in Biotechnology Friday?

The 45 rating InvestorsObserver gives to Fortress Biotech Inc (FBIO) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 52 percent of stocks in the Biotechnology industry, FBIO’s 45 overall rating means the stock scores better than 45 percent of all stocks.

Overall Score - 45
FBIO has an Overall Score of 45. Find out what this means to you and get the rest of the rankings on FBIO!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Fortress Biotech Inc Stock Today?

Fortress Biotech Inc (FBIO) stock has gained 2.53% while the S&P 500 has fallen -0.04% as of 10:22 AM on Friday, Dec 1. FBIO has risen $0.05 from the previous closing price of $1.98 on volume of 74,558 shares. Over the past year the S&P 500 has risen 12.01% while FBIO has fallen -79.54%. FBIO lost -$12.29 per share the over the last 12 months. Click Here to get the full Stock Report for Fortress Biotech Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App